Abstract：Objective To explore the presence of serum autoantibodies in patients with hepatitis B cirrhosis and its clinical significance. Methods 60 patients with hepatitis B cirrhosis in the Sixth People′s Hospital of Qingdao City from March 2016 to June 2017 were selected and divided into autoantibodies positive group (n=13) and autoantibodies negative group (n=47) according to the test results of serum autoantibodies which were detected with immunoblot. The liver function indexes of ALT, AST, TBil, AKP, GGT and immunoglobulin between two groups were detected by using full automatic biochemical analyzer. Liver instantaneous elastic hardness (Fibroscan) was tested. Results Total positive rate of autoantibodies in patients with hepatitis B cirrhosis was 21.7%. Compared with autoantibody negative group, the age of autoantibody positive group was increased (P < 0.05), the levels of GLB, IgG and Fibroscan were significantly increased in autoantibody positive group (P < 0.05), ALB of autoantibody positive group was decreased (P < 0.05). Conclusion Autoimmune reactions exist in patients with hepatitis B cirrhosis, and cause production of autoantibodies, which are related to the age, the degree of liver damage and liver fibrosis of paients.
[1] 谢守凤，杨静，王宁.自身抗体检测对肝病患者的鉴别诊断价值[J].胃肠病学和肝病学杂志，2015，24（5）：549-552.
[2] 黄瑛，林志，李波.药物诱导性自身免疫性疾病研究进展[J].中国新药杂志，2013，22（19）：2244-2249.
[3] Loria P，Lonardo A，Leonardi F，et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease：prevalence and correlates [J]. Digest Dis Sci，2003，48（11）：2173-2181.
[4] 黄金保，徐秀亮，胡义忠，等.病毒性肝炎患者血清自身抗体的变化[J].检验医学，2015，30（7）：731-733.
[5] 李文淑，赵景民，周光德，等.HCV感染者自身抗体对肝脏损伤的影响[J/CD].中华临床医师杂志：电子版，2011， 5（20）：5969-5973.
[6] Muratori P，Muratori L，Verucchi G，et al. Non-organ-specific autoantibodies in children with chronic hepatitis C：clinical significance and impact on interferon treatment [J]. CID，2003：37（15）：1320-1326.
[7] Chen CH，Lee CM，Chen CH，et al. Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C [J]. Chang Gung Med J，2010，33（3）：258-265.
[8] Marconcini ML，Fayad L，Shiozawa MB，et al. Autoantibody profile in individuals with chronic hepatitis C [J]. Rev Soc Bras Med Trop，2013，46（2）：147-153.
[9] 张海萍，闫惠平，冯霞，等.乙肝病毒感染者血清抗核抗体特征及临床相关性[J].首都医科大学学报，2007，28（2）：154-157.
[10] 聂红，王云英，王毅，等.不同基因型乙型肝炎病毒感染者与其自身抗体的相关性分析[J].中华肝脏病杂志，2012， 20（6）：448-452.
[11] Kansu A，Kulo■lu Z，Demir?觭eken F，et al. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha [J]. Turk J Gastroenterol，2004， 15（4）：213-218.
[12] 林晓梅，潘钦石，张文辉，等.慢性乙型肝炎患者产生自身免疫的研究[J].中华医院感染学杂志，2009，19（8）：889-891.
[13] 樊启艳，杨京.慢性HBV感染患者血清自身抗体的检测与临床意义[J].中国医学创新，2014，11（7）：27-29.
[14] Acay A，Demir K，Asik G，et al. Assessment of the frequency of autoantibodies in chronic viral hepatitis [J]. Pak J Med Sci，2015，31（1）：150-154.
[15] Squadrito G，Previti M，Lenzi M，et al. High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy [J]. Digest Dis Sci，2003，48（2）：349-353.
[16] Shantha S，Thyagarajan SP，Premavathy RK，et al. Correlation of autoimmune reactivity with hepatitis B and C virus（HBV and HCV）infection in histologically proven chronic liver diseases [J]. Indian J Med Microbiol，2002， 20（1）：12-15.
[17] 王波，丁楠，常波.乙型肝炎后肝硬化自身抗体检测及其对肝功能影响的研究[J].中国实验诊断学，2013，17（11）：2022-2025.
[18] 张占卿，陈淑琴，陆伟，等.血清免疫球蛋白诊断乙型肝炎相关肝硬化的价值[J].胃肠病学和肝病学杂志，2008， 17（10）：844-845，848.
[19] 张占卿，陆伟，饶敏，等.血清免疫球蛋白对慢性肝炎病理分级和分期的判别价值[J].肝脏，2008，13（4）：299-302.
[20] 范公忍，刘力瑞，胡学玲，等.乙型肝炎病毒感染者血清肝特异性自身抗体的检测及临床意义[J].实用肝脏病杂志，2013，16（5）：421-423.
2017, Vol. 14 
京公网安备 11010502046598号